Brand name: Cefepime (AFT)
Cefepime (AFT) is a medicine containing the active ingredient(s) cefepime. On this page you will find out more about Cefepime (AFT), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: cefepime
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Cefepime (AFT) 2 g powder for injection, 1 vial
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Adults: Cefepime-AFT is indicated in the treatment of the infections listed below when caused by susceptible bacteria. Lower respiratory tract infections, including pneumonia and bronchitis. Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. Skin and skin structure infections. Intra-abdominal infections, including peritonitis and biliary tract infections. Gynaecological infections. Septicaemia Empiric treatment in febrile neutropenic patients (See PRECAUTIONS) Cefepime-AFT is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. In this indication it is essential that metronidazole also be administered. Paediatrics: Cefepime-AFT is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria: Pneumonia Urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections Skin and skin structure infections Septicaemia Empiric treatment in febrile neutropenic patients (See PRECAUTIONS) Culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. Empiric therapy with Cefepime-AFT may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly. Because of its broad spectrum of bactericidal activity against gram-positive and gram-negative bacteria, Cefepime-AFT can be used appropriately as monotherapy prior to identification of the causative organisms(s). In the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with Cefepime-AFT. In patients who are at risk of mixed aerobic-anaerobic infection, including infections in which Bacterioides fragilis may be present, concurrent initial therapy with an anti-anaerobic agent is recommended before the causative organism(s) is known.
Table of characteristics
| Active ingredient | |
|---|---|
| Visual appearance | White to off white powder |
| Dosage Form | Injection, powder for |
| Route of administration | Intramuscular |
| Medicine schedule |
1 vial: Prescription Only Medicine, or Prescription Animal Remedy
10 vials: Prescription Only Medicine, or Prescription Animal Remedy
5 vials: Prescription Only Medicine, or Prescription Animal Remedy
|
There is one type of pack available.
Pack type 1
| Type | Vial |
|---|---|
| Storage temperature | Store below 25 degrees Celsius |
| Storage conditions | Store in Original Container,Protect from Light |
| Life time | 2 Years |
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
